FDA Clears First Device for Reduction of Opioid Withdrawal Symptoms

The FDA has cleared a new indication for Innovative Health Solutions’ electric nerve stimulation device for use in reducing opioid withdrawal symptoms as part of the agency’s continued efforts to address the U.S. opioid epidemic.

A chip contained in the NSS-2 Bridge device stimulates certain cranial nerves via electrical pulses to relieve acute physical withdrawal symptoms such as sweating, gastrointestinal upset, agitation, insomnia and joint pain.

The device can remain behind a patient’s ear for up to five days during the withdrawal phase.